To experimentally test if melanoma cells induce signaling through the MLCK pathway within endothelial cells to contribute to gap formation, we treated HUVEC monolayers with the MLCK inhibitor ML-7 for 30 minutes prior to co-culture with A2058 melanoma cells. Here, MYLK is linked to melanoma.